IBDEI0F9 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6998,2)
 ;;=^335321
 ;;^UTILITY(U,$J,358.3,6999,0)
 ;;=794.8^^31^417^1
 ;;^UTILITY(U,$J,358.3,6999,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6999,1,4,0)
 ;;=4^794.8
 ;;^UTILITY(U,$J,358.3,6999,1,5,0)
 ;;=5^Abn Liver Function Study
 ;;^UTILITY(U,$J,358.3,6999,2)
 ;;=^273450
 ;;^UTILITY(U,$J,358.3,7000,0)
 ;;=995.29^^31^417^2
 ;;^UTILITY(U,$J,358.3,7000,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7000,1,4,0)
 ;;=4^995.29
 ;;^UTILITY(U,$J,358.3,7000,1,5,0)
 ;;=5^Adv Eff Med/Bio NOS
 ;;^UTILITY(U,$J,358.3,7000,2)
 ;;=^334181
 ;;^UTILITY(U,$J,358.3,7001,0)
 ;;=995.3^^31^417^3
 ;;^UTILITY(U,$J,358.3,7001,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7001,1,4,0)
 ;;=4^995.3
 ;;^UTILITY(U,$J,358.3,7001,1,5,0)
 ;;=5^Allergic RX-Non Drug
 ;;^UTILITY(U,$J,358.3,7001,2)
 ;;=^60275
 ;;^UTILITY(U,$J,358.3,7002,0)
 ;;=V45.81^^31^418^1
 ;;^UTILITY(U,$J,358.3,7002,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7002,1,4,0)
 ;;=4^V45.81
 ;;^UTILITY(U,$J,358.3,7002,1,5,0)
 ;;=5^Aortocoronary Bypass
 ;;^UTILITY(U,$J,358.3,7002,2)
 ;;=^97129
 ;;^UTILITY(U,$J,358.3,7003,0)
 ;;=V43.3^^31^418^2
 ;;^UTILITY(U,$J,358.3,7003,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7003,1,4,0)
 ;;=4^V43.3
 ;;^UTILITY(U,$J,358.3,7003,1,5,0)
 ;;=5^Heart Valve Replacement
 ;;^UTILITY(U,$J,358.3,7003,2)
 ;;=^295440
 ;;^UTILITY(U,$J,358.3,7004,0)
 ;;=V42.2^^31^418^3
 ;;^UTILITY(U,$J,358.3,7004,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7004,1,4,0)
 ;;=4^V42.2
 ;;^UTILITY(U,$J,358.3,7004,1,5,0)
 ;;=5^Heart Valve Transplant
 ;;^UTILITY(U,$J,358.3,7004,2)
 ;;=^295437
 ;;^UTILITY(U,$J,358.3,7005,0)
 ;;=V45.01^^31^418^4
 ;;^UTILITY(U,$J,358.3,7005,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7005,1,4,0)
 ;;=4^V45.01
 ;;^UTILITY(U,$J,358.3,7005,1,5,0)
 ;;=5^Pacemaker Status
 ;;^UTILITY(U,$J,358.3,7005,2)
 ;;=^303419
 ;;^UTILITY(U,$J,358.3,7006,0)
 ;;=584.9^^31^419^4
 ;;^UTILITY(U,$J,358.3,7006,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7006,1,4,0)
 ;;=4^584.9
 ;;^UTILITY(U,$J,358.3,7006,1,5,0)
 ;;=5^Acute Renal Failure NOS
 ;;^UTILITY(U,$J,358.3,7006,2)
 ;;=^338532
 ;;^UTILITY(U,$J,358.3,7007,0)
 ;;=584.7^^31^419^1
 ;;^UTILITY(U,$J,358.3,7007,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7007,1,4,0)
 ;;=4^584.7
 ;;^UTILITY(U,$J,358.3,7007,1,5,0)
 ;;=5^AC Ren Fail w/Lesion Medull Necr
 ;;^UTILITY(U,$J,358.3,7007,2)
 ;;=^338530
 ;;^UTILITY(U,$J,358.3,7008,0)
 ;;=584.6^^31^419^3
 ;;^UTILITY(U,$J,358.3,7008,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7008,1,4,0)
 ;;=4^584.6
 ;;^UTILITY(U,$J,358.3,7008,1,5,0)
 ;;=5^AC Renal Fail w/Lesion of Renal Cort
 ;;^UTILITY(U,$J,358.3,7008,2)
 ;;=^338529
 ;;^UTILITY(U,$J,358.3,7009,0)
 ;;=584.6^^31^419^2
 ;;^UTILITY(U,$J,358.3,7009,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7009,1,4,0)
 ;;=4^584.6
 ;;^UTILITY(U,$J,358.3,7009,1,5,0)
 ;;=5^AC Renal Fail w/Lesion Tubular Necro
 ;;^UTILITY(U,$J,358.3,7009,2)
 ;;=^338529
 ;;^UTILITY(U,$J,358.3,7010,0)
 ;;=585.6^^31^420^6
 ;;^UTILITY(U,$J,358.3,7010,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7010,1,4,0)
 ;;=4^585.6
 ;;^UTILITY(U,$J,358.3,7010,1,5,0)
 ;;=5^End Stage Renal Disease
 ;;^UTILITY(U,$J,358.3,7010,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,7011,0)
 ;;=586.^^31^420^7
 ;;^UTILITY(U,$J,358.3,7011,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7011,1,4,0)
 ;;=4^586.
 ;;^UTILITY(U,$J,358.3,7011,1,5,0)
 ;;=5^Renal Failure NOS
 ;;^UTILITY(U,$J,358.3,7011,2)
 ;;=^104733
 ;;^UTILITY(U,$J,358.3,7012,0)
 ;;=585.1^^31^420^1
 ;;^UTILITY(U,$J,358.3,7012,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7012,1,4,0)
 ;;=4^585.1
 ;;^UTILITY(U,$J,358.3,7012,1,5,0)
 ;;=5^CHR Kid Dis,Stage I
